TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024)
TerrAscend's (TSNDF) quarterly Change in Accured Expenses came in at $85000.0 in Q4 2024, up 102.35% year-on-year from $42005.7 in Q1 2024, and up 34.92% on a QoQ basis from $63000.0 in Q3 2024.
TerrAscend (TSNDF) Change in Accured Expenses (2021 - 2024) Analysis & Trends
TerrAscend (TSNDF) has 4 years of Change in Accured Expenses data on file, last reported at $85000.0 in Q4 2024.
- On a quarterly basis, Change in Accured Expenses rose 102.35% year-over-year to $85000.0 in Q4 2024; TTM through Dec 2024 was -$388000.0, a 81.26% increase from a year earlier, with the FY2024 full-year figure at -$388000.0, up 81.26% from the prior year.
- Change in Accured Expenses for Q4 2024 stood at $85000.0, up from $63000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for TSNDF reached as high as $17.8 million in Q4 2021 and fell as low as -$9.9 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged $117692.3 across 4 years, with a median of -$14000.0 in 2023.
- Across the five-year window, Change in Accured Expenses jumped 136.23% in 2023 and tumbled 3735.71% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $17.8 million in 2021, then slumped by 123.66% to -$4.2 million in 2022, then gained by 14.39% to -$3.6 million in 2023, then surged by 102.35% to $85000.0 in 2024.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $85000.0 in Q4 2024, $63000.0 in Q3 2024, and $1000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 85,000.00 |
| Dec 31, 2024 | 85,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Mar 31, 2024 | -537,000.00 |
| Dec 31, 2023 | -3.61 Mn |
| Dec 31, 2023 | -3.61 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -159,000.00 |
| Jun 30, 2023 | -159,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -4.22 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Sep 30, 2022 | 726,000.00 |
| Sep 30, 2022 | 726,000.00 |